145 related articles for article (PubMed ID: 10783004)
1. Design and synthesis of new steroidal inhibitors of estrogen synthase (aromatase).
Parish EJ; Li S; Rao Z
Lipids; 2000 Mar; 35(3):271-7. PubMed ID: 10783004
[TBL] [Abstract][Full Text] [Related]
2. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
Ahmad I; Shagufta
Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of 6-phenylaliphatic-substituted C19 steroids having a 1,4-diene, 4,6-diene, or 1,4,6-triene structure as aromatase inhibitors.
Numazawa M; Yamaguchi S
Steroids; 1999 Mar; 64(3):187-96. PubMed ID: 10400379
[TBL] [Abstract][Full Text] [Related]
4. Aromatase inhibitors--mechanisms of steroidal inhibitors.
Brueggemeier RW
Breast Cancer Res Treat; 1994; 30(1):31-42. PubMed ID: 7949203
[TBL] [Abstract][Full Text] [Related]
5. 19-Oxygenation of C19-steroids with an A, B-ring enone structure, competitive inhibitors of estrogen biosynthesis, with human placental aromatase.
Numazawa M; Yamada K; Nagaoka M
Biol Pharm Bull; 2001 Apr; 24(4):332-5. PubMed ID: 11305590
[TBL] [Abstract][Full Text] [Related]
6. Exemestane, a new steroidal aromatase inhibitor of clinical relevance.
Lombardi P
Biochim Biophys Acta; 2002 Jul; 1587(2-3):326-37. PubMed ID: 12084475
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and evaluation of novel 16-imidazolyl substituted steroidal derivatives possessing potent diversified pharmacological properties.
Bansal R; Guleria S; Thota S; Bodhankar SL; Patwardhan MR; Zimmer C; Hartmann RW; Harvey AL
Steroids; 2012 May; 77(6):621-9. PubMed ID: 22366075
[TBL] [Abstract][Full Text] [Related]
8. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
[TBL] [Abstract][Full Text] [Related]
9. Molecular pharmacology of aromatase and its regulation by endogenous and exogenous agents.
Brueggemeier RW; Richards JA; Joomprabutra S; Bhat AS; Whetstone JL
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):75-84. PubMed ID: 11850210
[TBL] [Abstract][Full Text] [Related]
10. Aromatase inhibitors: past, present and future.
Séralini G; Moslemi S
Mol Cell Endocrinol; 2001 Jun; 178(1-2):117-31. PubMed ID: 11403901
[TBL] [Abstract][Full Text] [Related]
11. Rational design of allosteric modulators of the aromatase enzyme: An unprecedented therapeutic strategy to fight breast cancer.
Spinello A; Martini S; Berti F; Pennati M; Pavlin M; Sgrignani J; Grazioso G; Colombo G; Zaffaroni N; Magistrato A
Eur J Med Chem; 2019 Apr; 168():253-262. PubMed ID: 30822713
[TBL] [Abstract][Full Text] [Related]
12. Steroidal Oximes: Useful Compounds with Antitumor Activities.
Canario C; Silvestre S; Falcao A; Alves G
Curr Med Chem; 2018 Feb; 25(6):660-686. PubMed ID: 28971759
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Aromatase Inhibitory, Antiproliferative and Molecular Modeling Studies of Functionally Diverse D-Ring Pregnenolone Pyrazoles.
Banday AH; Saeed BA; Al-Masoudi NA
Anticancer Agents Med Chem; 2021; 21(13):1671-1679. PubMed ID: 33238853
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
Numazawa M; Kamiyama T; Tachibana M; Oshibe M
J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 16E-arylidenosteroids as cytotoxic and anti-aromatase agents.
Bansal R; Guleria S; Thota S; Hartmann RW; Zimmer C
Chem Pharm Bull (Tokyo); 2011; 59(3):327-31. PubMed ID: 21372413
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of a new type of non steroidal human aromatase inhibitors.
Sonnet P; Guillon J; Enguehard C; Dallemagne P; Bureau R; Rault S Auvray P; Moslemi S; Sourdiane P; Galopin S; Séralini GE
Bioorg Med Chem Lett; 1998 May; 8(9):1041-4. PubMed ID: 9871704
[TBL] [Abstract][Full Text] [Related]
17. Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer.
Yadav MR; Barmade MA; Tamboli RS; Murumkar PR
Eur J Med Chem; 2015 Nov; 105():1-38. PubMed ID: 26469743
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of new steroidal isoxazoles: inhibitors of estrogen synthase.
Li S; Parish EJ; Rodriguez-Valenzuela C; Brodie AM
Bioorg Med Chem; 1998 Sep; 6(9):1525-9. PubMed ID: 9801824
[TBL] [Abstract][Full Text] [Related]
19. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
Murphy MJ
Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
[TBL] [Abstract][Full Text] [Related]
20. Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation.
Ertas M; Sahin Z; Berk B; Yurttas L; Biltekin SN; Demirayak S
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700272. PubMed ID: 29522642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
